CORONA Remedies

冠状病毒疗法

on Thursday said it has acquired seven brands from the

周四表示，已从

pharmaceutical

制药的

division of

分割

Bayer

拜耳

in

在

India

印度

for an undisclosed sum.

金额未披露。

The

The

acquisition

收购

includes brands in the cardiology segment (Noklot) and

包括心血管领域（Noklot）的品牌以及

women's healthcare

女性健康护理

portfolio (Fostine, Luprofact, Menodac, Ovidac, Spye and Vageston) in the

投资组合（Fostine、Luprofact、Menodac、Ovidac、Spye 和 Vageston）在

Indian market

印度市场

, the company said in a statement.

，该公司在一份声明中表示。

Through the acquisition, the company said it is entering the anti-platelet

通过收购，该公司表示将进入抗血小板领域。

monotherapy

单药治疗

segment while also increasing presence in the cardiology domain.

同时增加在心脏病学领域的影响力。

(You can now subscribe to our

（你现在可以订阅我们的

Economic Times WhatsApp channel

经济时报 WhatsApp 频道

)

)

(You can now subscribe to our

（你现在可以订阅我们的

Economic Times WhatsApp channel

经济时报WhatsApp频道

)

)